Article
Multiple Omics Analysis Reveals E2F5 Predict Prognostic Biomarker in Diffuse Large B-Cell Lymphoma
2021-10-28
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is highly aggressive and fatal hematological malignancy. There are few biomarkers that can be used to predict the survival of DLBCL patients. Therefore, there is an urgent need to find new biological targets to improve the predictive value and sensitive diagnosis of DLBCL.E2F family play an essential role in tumorigenesis, however, remains obscure in DLBCL.E2F transcription fa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 89fbe253-78da-5ff4-8fc6-d0946da35126
- DOI
- 10.21203/rs.3.rs-996006/v1
